Testing two-shot prostate radiation with MRI-guided planning
Part of Cancer, Kidney & urinary clinical trials.
This early-phase study tests a prostate radiation approach given in two treatments, planned using MRI. It’s designed for men with lower-to-intermediate risk prostate cancer and aims to see if this method is safe and works well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have biopsy-proven prostate adenocarcinoma (prostate cancer found on biopsy)
- Your cancer is low to intermediate risk (not high risk) and is limited to the prostate area
- Your prostate is smaller than 60 cubic centimeters on the planning MRI
- You can have an MRI and have a prostate MRI lesion rated PI-RADS 3 or higher (unless you meet a very low/favorable group where a specific step may not be used)
- You can do the planned two-treatment radiation setup, including meeting the clinic’s bowel/urinary dose safety limits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests a focused radiation approach using stereotactic body radiation therapy (SBRT) for people with one prostate tumor visible on imaging. It aims to treat a single tumor area while limiting treatment to the rest of the prostate.
This study compares two ways of giving radiation to the prostate, including a “boost” using a special internal radiation treatment. It’s meant to see which radiation schedule works better and is safer for certain prostate cancer patients.
This trial tests a precise, MRI-guided radiation treatment given over 7 days for people with prostate cancer in specific risk categories. It may help shrink or control the cancer while carefully targeting the tumor.
This trial tests a very short, one-time form of radiation (SBRT) to treat prostate cancer. It aims to see whether treating the prostate in one shot is safe and effective for carefully selected patients.
This study tests a new radiation treatment approach that uses MRI imaging to target specific tumor areas within the prostate while reducing radiation to healthy tissue. It may help patients with early-stage prostate cancer get effective treatment with fewer side effects.
This trial is comparing two different MRI-guided radiation treatment plans to see which one better improves sexual quality of life in prostate cancer. It may help people decide between shorter or more treatment-session radiation approaches.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.